Koninklijke Philips Property, Plant, and Equipment 2010-2024 | PHG

Koninklijke Philips property, plant, and equipment from 2010 to 2024. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
  • Koninklijke Philips property, plant, and equipment for the quarter ending September 30, 2024 was $2.656B, a 9.03% decline year-over-year.
  • Koninklijke Philips property, plant, and equipment for 2023 was $2.687B, a 3.31% decline from 2022.
  • Koninklijke Philips property, plant, and equipment for 2022 was $2.779B, a 12.96% decline from 2021.
  • Koninklijke Philips property, plant, and equipment for 2021 was $3.193B, a 4.23% increase from 2020.
Koninklijke Philips Annual Property, Plant, and Equipment
(Millions of US $)
2023 $2,687
2022 $2,779
2021 $3,193
2020 $3,064
2019 $3,210
2018 $2,022
2017 $1,798
2016 $2,385
2015 $2,578
2014 $2,785
2013 $3,693
2012 $3,806
2011 $4,198
2010 $4,336
2009 $4,535
Koninklijke Philips Quarterly Property, Plant, and Equipment
(Millions of US $)
2024-06-30 $2,656
2023-09-30
2023-06-30 $2,747
2023-03-31
2022-06-30 $2,919
2021-06-30 $3,270
2020-06-30 $3,110
2019-06-30 $2,780
2018-06-30 $1,881
2017-06-30 $1,672
2016-12-31 $2,385
2016-09-30 $2,450
2016-06-30 $2,525
2016-03-31 $2,447
2015-12-31 $2,578
2015-09-30 $2,498
2015-06-30 $2,553
2015-03-31 $2,646
2014-12-31 $2,785
2014-09-30 $3,679
2014-06-30 $3,715
2014-03-31 $3,713
2013-12-31 $3,693
2013-09-30 $3,726
2013-06-30 $3,790
2013-03-31 $3,924
2012-12-31 $10,134
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $24.805B $19.663B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $204.249B 26.05
Stryker (SYK) United States $146.711B 33.06
Boston Scientific (BSX) United States $132.644B 38.14
EssilorLuxottica (ESLOY) France $112.106B 0.00
Medtronic (MDT) Ireland $110.562B 16.42
Haleon (HLN) United Kingdom $43.682B 28.38
Lonza Group Ag (LZAGY) Switzerland $42.166B 0.00
GE HealthCare Technologies (GEHC) United States $37.665B 19.54
ResMed (RMD) United States $35.786B 29.41
Terumo (TRUMY) Japan $29.739B 0.00
Zimmer Biomet Holdings (ZBH) United States $21.942B 13.97
Insulet (PODD) United States $18.443B 73.44
Baxter (BAX) United States $16.957B 11.03
Smith & Nephew SNATS (SNN) United Kingdom $11.065B 0.00
BellRing Brands (BRBR) United States $10.158B 40.72
Bio-Rad Laboratories (BIO) United States $9.320B 31.68
Demant (WILYY) Denmark $8.342B 0.00
Lantheus Holdings (LNTH) United States $6.294B 14.62
TG Therapeutics (TGTX) United States $5.459B 0.00
Haemonetics (HAE) United States $4.297B 20.97
Prestige Consumer Healthcare (PBH) United States $4.192B 20.85
ICU Medical (ICUI) United States $4.125B 39.27
Perrigo (PRGO) Ireland $3.830B 11.27
Envista Holdings (NVST) United States $3.697B 27.54
Neogen (NEOG) United States $3.246B 37.45
Agios Pharmaceuticals (AGIO) United States $3.175B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.841B 18.22
QuidelOrtho (QDEL) United States $2.700B 17.38
LeMaitre Vascular (LMAT) United States $2.428B 59.00
Warby Parker (WRBY) United States $2.349B 0.00
Green Thumb Industries (GTBIF) United States $1.913B 33.48
AtriCure (ATRC) United States $1.742B 0.00
InMode (INMD) Israel $1.597B 9.61
AdaptHealth (AHCO) United States $1.326B 9.48
Maravai LifeSciences Holdings (MRVI) United States $1.318B 0.00
Curaleaf Holdings (CURLF) Canada $1.267B 0.00
BioLife Solutions (BLFS) United States $1.207B 0.00
Phibro Animal Health (PAHC) United States $0.962B 16.96
Owens & Minor (OMI) United States $0.952B 7.44
CeriBell (CBLL) United States $0.943B 0.00
National Vision Holdings (EYE) United States $0.918B 30.68
Capricor Therapeutics (CAPR) United States $0.847B 0.00
Evolus (EOLS) United States $0.798B 0.00
VAREX IMAGING (VREX) United States $0.684B 30.25
Omeros (OMER) United States $0.632B 0.00
Surmodics (SRDX) United States $0.563B 0.00
Cresco Labs (CRLBF) United States $0.533B 0.00
Verano Holdings (VRNOF) United States $0.522B 0.00
Canopy Growth (CGC) Canada $0.468B 0.00
Quanterix (QTRX) United States $0.451B 0.00
ZimVie (ZIMV) United States $0.391B 32.95
Valneva SE (VALN) France $0.360B 0.00
Viemed Healthcare (VMD) United States $0.341B 32.41
Cerus (CERS) United States $0.332B 0.00
Sanara MedTech (SMTI) United States $0.330B 0.00
Biote (BTMD) United States $0.325B 7.12
OraSure Technologies (OSUR) United States $0.289B 19.40
Zynex (ZYXI) United States $0.263B 55.07
Aurora Cannabis (ACB) Canada $0.238B 0.00
TerrAscend (TSNDF) Canada $0.225B 0.00
Utah Medical Products (UTMD) United States $0.221B 15.29
High Tide (HITI) Canada $0.213B 88.33
MacroGenics (MGNX) United States $0.203B 0.00
Sanuwave Health (SNWV) United States $0.188B 2.64
Brainsway (BWAY) Israel $0.167B 100.00
Organigram Holdings (OGI) Canada $0.166B 0.00
Jin Medical (ZJYL) China $0.164B 0.00
Zevia PBC (ZVIA) United States $0.160B 0.00
FitLife Brands (FTLF) United States $0.149B 18.67
TriSalus Life Sciences (TLSI) United States $0.138B 0.00
Fonar (FONR) United States $0.104B 11.74
Quipt Home Medical (QIPT) United States $0.104B 0.00
Veru (VERU) United States $0.099B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.094B 23.40
Ayr Wellness (AYRWF) United States $0.077B 0.00
Rockwell Medical (RMTI) United States $0.073B 37.50
Exagen (XGN) United States $0.072B 0.00
Cellectar Biosciences (CLRB) United States $0.065B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
InterCure (INCR) Israel $0.062B 0.00
Modular Medical (MODD) United States $0.058B 0.00
MariMed (MRMD) United States $0.057B 0.00
Apyx Medical (APYX) United States $0.054B 0.00
Safety Shot (SHOT) United States $0.051B 0.00
Cytosorbents (CTSO) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.033B 0.00
Allurion Technologies (ALUR) United States $0.028B 0.00
Flora Growth (FLGC) United States $0.019B 0.00
Meihua Medical Technologies (MHUA) China $0.018B 0.00
Innovative Eyewear (LUCY) United States $0.016B 0.00
Nephros (NEPH) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.009B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Senestech (SNES) United States $0.002B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.83
SNDL (SNDL) Canada $0.000B 0.00